ACCENDRA HEALTH INC/VA/ (OMI) Form 8-K — Nov 2, 2026
Accendra Health (NYSE: ACH) announced that subsidiaries Accendra Funding LLC and Byram Healthcare entered into the Third Amendment to their Amended & Restated Receivables Purchase Agreement on October 29, 2026, extending the Scheduled Termination Date to October 2029. The $150 million size of the Receivables Sale Program is unchanged, and the amendment also revises account control provisions and reporting obligations. PNC Bank serves as Administrative Agent and PNC Capital Markets as Structuring Agent. CFO Jonathan Leon said the extension further ensures the Company's liquidity strength and demonstrates the strength of its accounts receivable portfolio.
Key figures
- New termination date
- October 2029
- Receivables program size
- $150 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.